Veerle A. Lantinga

Veerle A. Lantinga

Auto-generated profile, based on publicly available information

Veerle A. Lantinga

Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
OLOtto van Leeuwen
Otto van Leeuwen
SBSilke Bodewes
Silke Bodewes
VLVeerle A. Lantinga
Veerle A. Lantinga
MHMartijn P.D. Haring
Martijn P.D. Haring
ATAdam M. Thorne
Adam M. Thorne
RPRobert Porte
Robert Porte
Ex situ normothermic machine perfusion (NMP) is increasingly used for viability assessment of high‐risk donor livers, whereas dual hypothermic oxygenated machine perfusion (DHOPE) reduces ischemia‐reperfusion injury. We aimed to resuscitate and test the viability of initially‐discarded, high‐risk donor livers using sequential DHOPE and NMP with two different oxygen carriers: an artificial hemoglobin‐based oxygen carrier (HBOC) or red blood cells (RBC). In a prospective observational cohort study of 54 livers that underwent DHOPE‐NMP, the first 18 procedures were performed with a HBOC‐based perfusion solution and the subsequent 36 procedures were performed with an RBC‐based perfusion solution for the NMP phase. All but one livers were derived from extended criteria donation after circulatory death donors, with a median donor risk index of 2.84 (IQR 2.52–3.11). After functional assessment during NMP, 34 livers (63% utilization), met the viability criteria and were transplanted. One‐year graft and patient survival were 94% and 100%, respectively. Post‐transplant cholangiopathy occurred in 1 patient (3%). There were no significant differences in utilization rate and post‐transplant outcomes between the HBOC and RBC group. Ex situ machine perfusion using sequential DHOPE‐NMP for resuscitation and viability assessment of high‐risk donor livers results in excellent transplant outcomes, irrespective of the oxygen carrier used.

5 April 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
IBIsabel M.A. Brüggenwirth
Isabel M.A. Brüggenwirth
MMMatteo Mueller
Matteo Mueller
VLVeerle A. Lantinga
Veerle A. Lantinga
SCStefania Camagni
Stefania Camagni
RCRiccardo De Carlis
Riccardo De Carlis
VMVincent E. de Meijer
Vincent E. de Meijer
A short period (1–2 h) of hypothermic oxygenated machine perfusion (HOPE) after static cold storage is safe and reduces ischemia‐reperfusion injury‐related complications after liver transplantation. Machine perfusion time is occasionally prolonged for logistical reasons, but it is unknown if prolonged HOPE is safe and compromises outcomes. We conducted a multicenter, observational cohort study of patients transplanted with a liver preserved by prolonged (≥4 h) HOPE. Postoperative biochemistry, complications, and survival were evaluated. The cohort included 93 recipients from 12 European transplant centers between 2014–2021. The most common reason to prolong HOPE was the lack of an available operating room to start the transplant procedure. Grafts underwent HOPE for a median (range) of 4:42 h (4:00–8:35 h) with a total preservation time of 10:50 h (5:50–20:50 h). Postoperative peak ALT was 675 IU/L (interquartile range 419–1378 IU/L). The incidence of postoperative complications was low, and 1‐year graft and patient survival were 94% and 88%, respectively. To conclude, good outcomes are achieved after transplantation of donor livers preserved with prolonged (median 4:42 h) HOPE, leading to a total preservation time of almost 21 h. These results suggest that simple, end‐ischemic HOPE may be utilized for safe extension of the preservation time to ease transplantation logistics.

30 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ATAdam M. Thorne
Adam M. Thorne
JWJustina Clarinda Wolters
Justina Clarinda Wolters
BLBianca Lascaris
Bianca Lascaris
SBSilke Bodewes
Silke Bodewes
VLVeerle A. Lantinga
Veerle A. Lantinga
VMVincent E. de Meijer
Vincent E. de Meijer
Normothermic machine perfusion (NMP) after static cold storage is increasingly used for preservation and assessment of human donor livers prior to transplantation. Biliary viability assessment during NMP reduces the risk of post-transplant biliary complications. However, understanding of molecular changes in the biliary system during NMP remains incomplete. We performed an in-depth, unbiased proteomics analysis of bile collected during sequential hypothermic machine perfusion, rewarming and NMP of 55 human donor livers. Longitudinal analysis during NMP reveals proteins reflective of cellular damage at early stages, followed by upregulation of secretory and immune response processes. Livers with bile chemistry acceptable for transplantation reveal protein patterns implicated in regenerative processes, including cellular proliferation, compared to livers with inadequate bile chemistry. These findings are reinforced by detection of regenerative gene transcripts in liver tissue before machine perfusion. Our comprehensive bile proteomics and liver transcriptomics data sets provide the potential to further evaluate molecular mechanisms during NMP and refine viability assessment criteria.

17 January 2022 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
IBIsabel M A Brüggenwirth
Isabel M A Brüggenwirth
VLVeerle A Lantinga
Veerle A Lantinga
MRMichel Rayar
Michel Rayar
ABAad P van Den Berg
Aad P van Den Berg
HBHans Blokzijl
Hans Blokzijl
VMVincent E. de Meijer
Vincent E. de Meijer
Introduction End-ischaemic preservation of a donor liver by dual hypothermic oxygenated machine perfusion (DHOPE) for 2 hours prior to transplantation is sufficient to mitigate ischaemia-reperfusion damage and fully restore cellular energy levels. Clinical studies have shown beneficial outcomes after transplantation of liver grafts preserved by DHOPE compared with static cold storage. In addition to graft reconditioning, DHOPE may also be used to prolong preservation time, which could facilitate logistics for allocation and transplantation globally. Methods and analysis This is a prospective, pseudo-randomised, dual-arm, IDEAL-D (Idea, Development, Exploration, Assessment, Long term study-Framework for Devices) stage 2 clinical device trial designed to determine safety and feasibility of prolonged DHOPE (DHOPE-PRO). The end-time of the donor hepatectomy will determine whether the graft will be assigned to the intervention (16:00–3:59 hour) or to the control arm (4:00–15:59 hour). In total, 36 livers will be included in the study. Livers in the intervention group (n=18) will undergo DHOPE-PRO (≥4 hours) until implantation the following morning, whereas livers in the control group (n=18) will undergo regular DHOPE (2 hours) prior to implantation. The primary endpoint of this study is a composite of the occurrence of all (serious) adverse events during DHOPE and up to 30 days after liver transplantation. Ethics and dissemination The protocol was approved by the Medical Ethical Committee of Groningen, METc2020.126 in June 2020, and the study was registered in the Netherlands National Trial Registry (https://www.trialregister.nl/) prior to initiation. Trial registration number NL8740.

7 September 2022 in Artificial Organs
Verified
Journal Article
Open access
RSRianne Schutter
Rianne Schutter
OVOtis C. van Varsseveld
Otis C. van Varsseveld
VLVeerle A. Lantinga
Veerle A. Lantinga
MPMerel B. F. Pool
Merel B. F. Pool
THTim H. Hamelink
Tim H. Hamelink
CMCyril Moers
Cyril Moers
Background: The shortage of donor organs for transplantation remains a worldwide problem. The utilization of suboptimal deceased donors enlarges the pool of potential organs, yet consequently, clinicians face the difficult decision of whether these sub‐optimal organs are of sufficient quality for transplantation. Novel technologies could play a pivotal role in making pre‐transplant organ assessment more objective and reliable.Methods: Ex vivo normothermic machine perfusion (NMP) at temperatures around 35–37°C allows organ quality assessment in a near‐physiological environment. Advanced magnetic resonance imaging (MRI) techniques convey unique information about an organ's structural and functional integrity. The concept of applying magnetic resonance imaging during renal normothermic machine perfusion is novel in both renal and radiological research and we have developed the first MRI‐compatible NMP setup for human‐sized kidneys.Results: We were able to obtain a detailed and real‐time view of ongoing processes inside renal grafts during ex vivo perfusion. This new technique can visualize structural abnormalities, quantify regional flow distribution, renal metabolism, and local oxygen availability, and track the distribution of ex vivo administered cellular therapy.Conclusion: This platform allows for advanced pre‐transplant organ assessment, provides a new realistic tool for studies into renal physiology and metabolism, and may facilitate therapeutic tracing of pharmacological and cellular interventions to an isolated kidney.

13 April 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
THTim L. Hamelink
Tim L. Hamelink
BOBaran Ogurlu
Baran Ogurlu
CPCarolina C. Pamplona
Carolina C. Pamplona
JCJohannes Castelein
Johannes Castelein
SBSigrid S. Bennedsgaard
Sigrid S. Bennedsgaard
CMCyril Moers
Cyril Moers
Normothermic machine perfusion (NMP) is increasingly considered for pre-transplant kidney quality assessment. However, fundamental questions about differences between in vivo and ex vivo renal function, as well as the impact of ischemic injury on ex vivo physiology, remain unanswered. This study utilized magnetic resonance imaging (MRI), alongside conventional parameters to explore differences between in vivo and ex vivo renal function and the impact of warm ischemia on a kidney's behavior ex vivo. Renal MRI scans and samples were obtained from living pigs (n=30) in vivo. Next, kidney pairs were procured and exposed to minimal, or 75 min of warm ischemia, followed by 6 hours of hypothermic machine perfusion. Both kidneys simultaneously underwent 6-hour ex vivo perfusion in MRI-compatible NMP circuits to obtain multiparametric MRI data. Ischemically injured ex vivo kidneys showed a significantly altered regional blood flow distribution compared to in vivo and to minimally damaged organs. Both ex vivo groups showed diffusion restriction relative to in vivo. Our findings underscore the differences between in vivo and ex vivo MRI-based renal characteristics. Therefore, when assessing organ viability during NMP, it should be considered to incorporate parameters beyond the conventional functional markers that are common in vivo.